Published in EMBO J on July 02, 2001
A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci U S A (2003) 2.94
Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron (2014) 2.83
Prion strain discrimination in cell culture: the cell panel assay. Proc Natl Acad Sci U S A (2007) 2.30
New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural products. J Virol (2003) 2.09
Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res. J Virol (2006) 1.35
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. Acta Neuropathol (2013) 1.34
Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly cell- and tissue-dependent. J Biol Chem (2010) 1.14
Prion strain-dependent differences in conversion of mutant prion proteins in cell culture. J Virol (2006) 1.14
Transfer of a prion strain to different hosts leads to emergence of strain variants. Proc Natl Acad Sci U S A (2010) 1.11
Biological and biochemical characteristics of prion strains conserved in persistently infected cell cultures. J Virol (2005) 1.11
Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides. Antimicrob Agents Chemother (2006) 1.08
Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin-tagging of amyloid precursor protein and prion proteins. Mol Biol Cell (2008) 1.08
Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains. J Virol (2006) 1.05
Recent advances in prion chemotherapeutics. Infect Disord Drug Targets (2009) 1.03
Down-regulation of Shadoo in prion infections traces a pre-clinical event inversely related to PrP(Sc) accumulation. PLoS Pathog (2011) 0.96
Cellular aspects of prion replication in vitro. Viruses (2013) 0.95
Low density subcellular fractions enhance disease-specific prion protein misfolding. J Biol Chem (2010) 0.94
In vitro amplification of misfolded prion protein using lysate of cultured cells. PLoS One (2011) 0.91
Prion propagation in cells expressing PrP glycosylation mutants. J Virol (2011) 0.88
Manganese enhances prion protein survival in model soils and increases prion infectivity to cells. PLoS One (2009) 0.87
Structural requirements for efficient prion protein conversion: cofactors may promote a conversion-competent structure for PrP(C). Prion (2010) 0.86
The standard scrapie cell assay: development, utility and prospects. Viruses (2015) 0.86
Infectious prions accumulate to high levels in non proliferative C2C12 myotubes. PLoS Pathog (2013) 0.86
Activation of the AMPK-ULK1 pathway plays an important role in autophagy during prion infection. Sci Rep (2015) 0.83
CRBL cells: establishment, characterization and susceptibility to prion infection. Brain Res (2008) 0.82
Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines. PLoS One (2009) 0.82
Generation of a persistently infected MDBK cell line with natural bovine spongiform encephalopathy (BSE). PLoS One (2015) 0.80
Diphenylpyrazole-derived compounds increase survival time of mice after prion infection. Antimicrob Agents Chemother (2011) 0.79
Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms. J Biol Chem (2012) 0.78
Re-infection of the prion from the scrapie‑infected cell line SMB-S15 in three strains of mice, CD1, C57BL/6 and Balb/c. Int J Mol Med (2016) 0.77
Mechanistic insights into the cure of prion disease by novel antiprion compounds. J Virol (2007) 0.77
Replication of prions in differentiated muscle cells. Prion (2014) 0.77
Susceptibility of cell substrates to PrPSc infection and safety control measures related to biological and biotherapeutical products. Prion (2008) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal Biochem (1984) 19.70
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature (1996) 14.40
Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01
Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science (1996) 6.71
Cell-free formation of protease-resistant prion protein. Nature (1994) 6.07
Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol (1994) 5.12
Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet (1961) 4.67
Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature (1995) 4.22
N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol (1991) 3.55
Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol (1988) 3.37
Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem (1995) 3.20
Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol (1993) 3.07
A 'unified theory' of prion propagation. Nature (1991) 2.87
Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A (1996) 2.79
Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem (1998) 2.65
Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol (1987) 2.54
Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem (1997) 2.48
Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol (1990) 2.42
Cultured cell sublines highly susceptible to prion infection. J Virol (2000) 2.38
A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol (1997) 2.32
Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nat Genet (1998) 2.23
Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol (2000) 2.18
Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell (1992) 2.14
Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest (1991) 2.13
Prion research: the next frontiers. Nature (1997) 2.13
Scrapie strain variation and mutation. Br Med Bull (1993) 2.06
Microsatellites for linkage analysis of genetic traits. Trends Genet (1992) 2.05
Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol (1988) 1.92
Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected]. J Virol (1994) 1.85
Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Sträussler-Scheinker disease. Proc Natl Acad Sci U S A (1998) 1.85
Selective neuronal targeting in prion disease. Neuron (1997) 1.82
Biochemical typing of scrapie strains. Nature (1997) 1.59
Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J Biol Chem (1995) 1.51
Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Pathol (1961) 1.48
Chemoprophylaxis of scrapie in mice. J Gen Virol (1991) 1.45
PrPc glycoform heterogeneity as a function of brain region: implications for selective targeting of neurons by prion strains. J Neuropathol Exp Neurol (1999) 1.31
Evidence for the multiplication of scrapie agent in cell culture. Nature (1970) 1.23
Multiplication of the scrapie agent. Nature (1971) 1.07
Characterization and polyanion-binding properties of purified recombinant prion protein. Biochem J (1999) 0.97
Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol (1995) 0.93
Scrapie--a personal view. J Clin Pathol Suppl (R Coll Pathol) (1972) 0.81
Scrapie strain infection in vitro induces changes in neuronal cells. Mol Neurobiol (1995) 0.80
Expanding the prion model for the yeast [PSI+] element. Trends Microbiol (2000) 0.78
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
Transmission of BSE by blood transfusion in sheep. Lancet (2000) 5.16
Does the agent of scrapie replicate without nucleic acid? Nature (1967) 4.14
DNA synthesis in the fission yeast Schizosaccharomyces pombe. Exp Cell Res (1970) 3.29
The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun (1966) 2.83
Biological evidence that scrapie agent has an independent genome. J Gen Virol (1987) 2.76
Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos Trans R Soc Lond B Biol Sci (1994) 2.76
Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies. Psychol Med (2012) 2.17
Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nat Med (1999) 2.14
Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med (2001) 1.99
Transmission of bovine spongiform encephalopathy and scrapie to mice. J Gen Virol (1992) 1.90
Experimental production of fatal mucosal disease in cattle. Vet Rec (1984) 1.87
Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet (2001) 1.84
An evaluation of the double thymidine block for synchronizing mammalian cells at the G1-S border. Exp Cell Res (1971) 1.83
PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice. J Pathol (1992) 1.79
Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med (2000) 1.78
Genetic apparatus of Stylonychia sp. Nature (1973) 1.72
Homologous subfamilies of human alphoid repetitive DNA on different nucleolus organizing chromosomes. Proc Natl Acad Sci U S A (1987) 1.69
Inactivation of the scrapie agent by near monochromatic ultraviolet light. Nature (1970) 1.66
Molecular analysis of ovine prion protein identifies similarities between BSE and an experimental isolate of natural scrapie, CH1641. J Gen Virol (1999) 1.62
Specific arrangements of human satellite III DNA sequences in human chromosomes. Chromosoma (1979) 1.57
Localisation of a male-specific DNA fragment to a sub-region of the human Y chromosome. Nature (1978) 1.55
Chromosome-specific subfamilies within human alphoid repetitive DNA. J Mol Biol (1986) 1.54
Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy. J Pathol (2000) 1.45
Satellite DNA in large marker chromosomes of methotrexate-resistant mouse cells. Cell (1980) 1.43
The potential size and duration of an epidemic of bovine spongiform encephalopathy in British sheep. Science (2001) 1.42
Mouse inoculation studies reveal no transmissible agent in amyotrophic lateral sclerosis. Brain Pathol (1996) 1.40
Variation in the intracellular polypeptide profiles from different isolates of bovine virus diarrhoea virus. Arch Virol (1987) 1.39
Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet Rec (1995) 1.39
Gene amplification in methotrexate-resistant mouse cells. II. Rearrangement and amplification of non-dihydrofolate reductase gene sequences accompany chromosomal changes. J Mol Biol (1981) 1.35
Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J Virol (2000) 1.34
Scrapie infections initiated at varying doses: an analysis of 117 titration experiments. Philos Trans R Soc Lond B Biol Sci (2000) 1.34
A study of sequence homologies in four satellite DNAs of man. J Mol Biol (1979) 1.31
The development of resistance to methotrexate in a mouse melanoma cell line. I. Characterisation of the dihydrofolate reductases and chromosomes in sensitive and resistant cells. Chromosoma (1979) 1.29
Detection of BSE infectivity in brain and spleen of experimentally infected sheep. Vet Rec (1996) 1.24
Cell death induced by cytopathic bovine viral diarrhoea virus is mediated by apoptosis. J Gen Virol (1996) 1.23
Evidence for the multiplication of scrapie agent in cell culture. Nature (1970) 1.23
Infectious etiology of neuritic (senile) plaques in mice. Science (1975) 1.23
Gene amplification in methotrexate-resistant mouse cells. III. Interrelationships between chromosome changes and DNA sequence amplification or loss. J Mol Biol (1981) 1.23
Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis. A caspase-independent cell clearance program. J Biol Chem (2000) 1.20
The transcription of Xenopus laevis embryonic U1 snRNA genes changes when oocytes mature into eggs. Genes Dev (1987) 1.20
Pathogenesis and epidemiology of bovine virus diarrhoea virus infection of cattle. Ann Rech Vet (1987) 1.19
Effect of route of infection on the frequency and distribution of cerebral amyloid plaques in scrapie mice. Neuropathol Appl Neurobiol (1981) 1.15
Pathogenesis of mouse scrapie: distribution of agent in the pulp and stroma of infected spleens. Vet Microbiol (1984) 1.13
T-lymphocyte activation and the cellular form of the prion protein. Immunology (1997) 1.13
Tagging genomic sequences that direct transgene expression by activation of a promoter trap in plants. Transgenic Res (1993) 1.11
Studies on the infectivity of foot-and-mouth disease virus RNA using microinjection. J Gen Virol (1988) 1.10
Infection of a cell line of mouse L fibroblasts with scrapie agent. Nature (1976) 1.09
Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice. Neuropathol Appl Neurobiol (2003) 1.09
Functional characteristics of the large lungs found in commercial divers. J Appl Physiol Respir Environ Exerc Physiol (1979) 1.09
Comparison by the neutralisation assay of pairs of non-cytopathogenic and cytopathogenic strains of bovine virus diarrhoea virus isolated from cases of mucosal disease. Vet Microbiol (1987) 1.09
The immunobiology of TSE diseases. J Gen Virol (2001) 1.08
Multiplication of the scrapie agent. Nature (1971) 1.07
Multiplication of scrapie agent in mouse spleen. Res Vet Sci (1971) 1.07
Synthesis of enzymes and DNA in synchronous cultures of Schizosaccharomyces pombe. Nature (1966) 1.06
In vivo toxicity of prion protein in murine scrapie: ultrastructural and immunogold studies. Neuropathol Appl Neurobiol (1997) 1.05
Mechanisms of DNA sequence amplification and their evolutionary consequences. Philos Trans R Soc Lond B Biol Sci (1986) 1.02
Gene amplification in methotrexate-resistant mouse cells. IV. Different DNA sequences are amplified in different resistant lines. Nucleic Acids Res (1982) 1.02
Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells. J Gen Virol (2000) 1.01
Immunostaining of scrapie cerebral amyloid plaques with antisera raised to scrapie-associated fibrils (SAF). Neuropathol Appl Neurobiol (1989) 1.00
Severely combined immunodeficient (SCID) mice resist infection with bovine spongiform encephalopathy. J Gen Virol (1997) 1.00
Accessibility of DNA in condensed chromatin to nuclease digestion. Nature (1976) 0.99
Multiplication of scrapie agent in cell culture. Res Vet Sci (1970) 0.99
The scrapie agent: evidence against its dependence for replication on intrinsic nucleic acid. J Gen Virol (1978) 0.99
Infection specific prion protein (PrP) accumulates on neuronal plasmalemma in scrapie infected mice. Neurosci Lett (1992) 0.99
Absence of detectable infectivity in trachea of BSE-affected cattle. Vet Rec (1996) 0.98
A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases. Diagn Immunol (1986) 0.98
Characterization and polyanion-binding properties of purified recombinant prion protein. Biochem J (1999) 0.97
Lability of 26 S ribosomal RNA in Tetrahymena pyriformis. Exp Cell Res (1971) 0.97
Agent replication dynamics in a long incubation period model of mouse scrapie. J Gen Virol (1985) 0.96
Genetic control of amyloid plaque production and incubation period in scrapie-infected mice. J Neuropathol Exp Neurol (1985) 0.95
Timing of replication of the satellite and main band DNAs in cells of the kangaroo rat (Dipodomys ordii). Exp Cell Res (1972) 0.95
Heparan sulfate proteoglycan is associated with amyloid plaques and neuroanatomically targeted PrP pathology throughout the incubation period of scrapie-infected mice. Exp Neurol (1998) 0.94
Different subfamilies of alphoid repetitive DNA are present on the human and chimpanzee homologous chromosomes 21 and 22. EMBO J (1987) 0.94
Presence of the transmissible agent of scrapie in the serum of affected mice and rats. Vet Rec (1967) 0.94
Effects of age on cerebral amyloid plaques in murine scrapie. Neuropathol Appl Neurobiol (1982) 0.94
Immunodetection of PrPSc in spleens of some scrapie-infected sheep but not BSE-infected cows. J Gen Virol (1997) 0.94
Determination of the frequency and distribution of vascular and parenchymal amyloid with polyclonal and N-terminal-specific PrP antibodies in scrapie-affected sheep and mice. Vet Rec (1998) 0.93
Focal and asymmetrical vacuolar lesions in the brains of mice infected with certain strains of scrapie. Acta Neuropathol (1982) 0.93
Murine scrapie infection causes an abnormal germinal centre reaction in the spleen. J Comp Pathol (2004) 0.92
An enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to bovine viral diarrhoea virus (BVDV) in cattle sera. Vet Microbiol (1985) 0.92
The occurrence in mice of facial and mandibular abscesses associated with Staphylococcus aureus. Lab Anim (1978) 0.92
Evidence of gene diminution during the formation of the macronucleus in the protozoan, Stylonychia (DNA density-melting curves-micronuclear DNA-polytene chromosomes). Proc Natl Acad Sci U S A (1972) 0.91
Straining the prion hypothesis. Nature (1998) 0.91
Experimental infection of cattle in early pregnancy with a cytopathic strain of bovine virus diarrhoea virus. Res Vet Sci (1989) 0.90
Morphogenesis of amyloid plaques in 87V murine scrapie. Neuropathol Appl Neurobiol (1994) 0.90
Ultrastructural immuno-localization of synthetic prion protein peptide antibodies in 87V murine scrapie. Neurodegeneration (1996) 0.90
Analysis of the frequency of sister chromatid exchange in different regions of chromosomes of the kangaroo rat (Dipodomys ordii). Chromosoma (1976) 0.89
Mitochondrial DNA in the fission yeast Schizosaccharomyces pombe. Biochim Biophys Acta (1969) 0.89
Transmission of feline spongiform encephalopathy to mice. Vet Rec (1994) 0.89
The antibody response of scrapie-affected mice to immunisation with sheep red blood cells. Res Vet Sci (1968) 0.88
Location of satellite DNAs in the chromosomes of the kangaroo rat (Dipodomys ordii). Chromosoma (1973) 0.87
Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody. Vet Microbiol (1989) 0.87
Retinopathy in mice with experimental scrapie. Neuropathol Appl Neurobiol (1986) 0.87
Trial of a capripoxvirus-rinderpest recombinant vaccine in African cattle. Epidemiol Infect (1997) 0.87
Shift in buoyant density of DNA during the synthetic period and its relation to euchromatin and heterochromatin in mammalian cells. J Mol Biol (1971) 0.87
Development of the polymerase chain reaction for the detection of bluetongue virus in tissue samples. J Virol Methods (1990) 0.86